logo

Quick Facts

Share SHARE

The AES Corp. (AES) announced the company is expecting 2017 ranges for Consolidated Net Cash Provided by Operating Activities of $2.00 to $2.80 billion, Consolidated Free Cash Flow of $1.40 to $2.00 billion and adjusted EPS of $1.00 to $1.10. The company expects to raise at least $500 million in equity...

Italian lender Intesa Sanpaolo S.p.A. (IITSF, ISNPY) said late Friday it has decided against a possible industrial combination with insurer Assicurazioni Generali SpA (ARZGY.PK). Intesa Sanpaolo said it has completed its assessment of options relating to a possible combination, but its management...

Total SA (TOT, TTA.L) Monday said it has signed an agreement for the sale of stakes and the transfer of operatorship in various mature assets in Gabon to Perenco. The total value of the transactions is around $350 million before adjustments. The production divested by Total represents around 13,000 SEC...

Keysight Technologies, Inc. (KEYS) on Monday announced a technology collaboration with Samsung Electronics Co. (SMSN.L, SSNNF.OB, SSNLF.OB) on 5G development and testing. Under the deal, the companies will enable design and deployment of 5G devices to support early operator trials. The initial focus...

Pfeiffer Vacuum Technology AG (PFFVF.PK, PVTCY.PK) announced the company's Management Board and Supervisory Board have advised shareholders to not accept the Busch Group's offer. The Boards deemed the offer price and structure are inadequate. The Busch Group stated in the offer document that it considers...

CTI BioPharma Corp. (CTIC) announced the appointment of Adam Craig as President and CEO and member of the Board, effective March 20. Craig succeeds Richard Love, interim President and CEO who will continue to serve on the company's Board. Craig has over 20 years of experience in hematology, oncology...

French drug giant Sanofi SA (SNYNF, SNY) and Lonza Group AG (LZAGF.PK), a supplier to the pharmaceutical, healthcare and life-science industries, announced Monday that they have entered into a strategic partnership to establish a large-scale biologics production facility in Switzerland. The initial investment...

VimpelCom Ltd. (VIP) reported that its fourth-quarter loss from continued operations widened to $273 million from a loss of $154 million, previous year. Operating profit decreased to $91 million from $166 million. Underlying EBITDA organically increased 1.2%. Profit to owners of the parent was $1.64...

South African integrated energy and chemicals company Sasol Ltd. (SSL) reported Monday that its six-month earnings attributable to shareholders increased 19% to R8,7 billion from R7,3 billion in the prior period. Earnings per share increased 19% from last year to R14,21. Headline earnings per share...

AT&T Inc. (T) on Monday announced new unlimited wireless and entertainment deals. Beginning this Thursday, its wireless customers can get new AT&T Unlimited Plus wireless plan, with unlimited amount of entertainment at unlimited wireless data. Customers on the plan will receive a $25 monthly video...

Merck (MRK) said that the European Committee for Medicinal Products for Human Use or CHMP has granted a positive opinion for the new Pergoveris Pen. The new Pen is comprised of a ready-to-use liquid version of Pergoveris evolved from a freeze-dried powder and solvent combination, available in vials,...

ANI Pharmaceuticals Inc. (ANIP) said that it has acquired Inderal XL from Cranford Pharmaceuticals LLC and InnoPran XL from Holmdel Pharmaceuticals LP. The acquired assets include the NDA and trademark for InnoPran XL® including a license to an Orange Book listed patent, and a distribution license...

AES Corp. (AES) and Alberta Investment Management Corp. or AIMCo, on behalf of certain of its clients, have agreed to acquire FTP Power LLC (sPower), the largest independent owner, operator and developer of utility scale solar assets in the United States, from Fir Tree Partners and its minority owners,...

Realogy Holdings Corp. (RLGY) announced its Board has authorized a new share repurchase program of up to $300 million of the company's common stock. This is in addition to the $61 million remaining under the current $275 million share repurchase authorization announced in February 2016. On February...

Novartis (NVS) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a positive opinion recommending approval of Tafinlar (dabrafenib) in combination with Mekinist (trametinib) to treat patients with advanced or metastatic non-small cell lung cancer...

Follow RTT